Related Experiment Video
Updated: Jun 24, 2026

Recombinant Protein Expression, Crystallization, and Biophysical Studies of a Bacillus-conserved Nucleotide Pyrophosphorylase, BcMazG
Published on: May 16, 2017
Parasporin, a new anticancer protein group from Bacillus thuringiensis
Michio Ohba1, Eiichi Mizuki, Akiko Uemori
1Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
Abstract:
Parasporin (PS) is a collection of genealogically heterogeneous Cry proteins synthesized in Bacillus thuringiensis. A prominent feature commonly associated with PS proteins is the strong cytocidal activity preferential for human cancer cells of various origins. The proteins exhibit cytocidal activities only when digested with proteases. Currently, this protein group is classified into four families: PS1, PS2, PS3 and PS4. Marked differences are evident in cytotoxicity spectra and activity levels between the four PS families. Neither hemolytic activity nor insect toxicity is associated with PS proteins. One of the most striking aspects in the events induced by PS1Aa1 is the early and rapid increase of the intracellular Ca2+ concentration, with no change in plasma membrane permeability. There is strong evidence that PS1Aa1 kills cancer cells through apoptosis. Unlike PS1Aa1, PS2Aa1 increases plasma membrane permeability of cancer cells. The initial step in cytocidal action of PS2Aa1 is the specific binding of this cytotoxin to a putative receptor located in the lipid rafts, followed by its oligomerization and pore formation in plasma membrane.
Related Concept Videos
Production of Biopesticides
Endospores and Sporulation
Gene Regulation During Sporulation
Recombinant DNA
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Production of Pharmaceuticals
